Office-Based Educational Handout for Influenza Vaccination: A Randomized Controlled Trial by Scott, VP et al.
 1 
Office-Based Educational Handout for Influenza Vaccination: 1 
A Randomized Controlled Trial 2 
 3 
Vanessa P. Scott, MD, MS,a,b Douglas J. Opel, MD, MPHc, Jason Reifler, PhD,d Sharon Rikin, 4 
MD, MS,b,e Kalpana Pethe, MD,a,b Angela Barretta, Melissa S. Stockwell, MD, MPHa,b,f 5 
 6 
Affiliations: aDepartment of Pediatrics, Columbia University, New York, NY, United States; 7 
bNewYork Presbyterian Hospital, New York, NY, United States; cSeattle Children’s Research 8 
Institute and Department of Pediatrics, University of Washington School of Medicine, Seattle, 9 
WA, United States; dDepartment of Politics, University of Exeter, Exeter, Devon, United 10 
Kingdom; eDepartment of Medicine, Columbia University, New York, NY, United States; 11 
fDepartment of Population and Family Health, Columbia University, New York, NY, United 12 
States.  13 
 14 
Address correspondence to: 15 
Melissa S. Stockwell, MD, MPH 16 
Division of Child and Adolescent Health, Columbia University 17 
622 W. 168th Street - VC 417; New York, NY 10032 18 
Tel: 212-342-5732; Fax: 212-305-8819; Email: mss2112@cumc.columbia.edu  19 
 20 
Short Title: Office-Based Educational Handout for Flu Vaccination 21 
 22 
Funding Source: Funding provided by the Health Resources and Services Administration, Ruth L. 23 
Kirschstein National Research Service Award Institutional Research Training Grant T0BHP293020100. 24 
    25 
Financial Disclosure: M.S.S. was an unremunerated coinvestigator for an unrelated, 26 
investigator-initiated grant from the Pfizer Medical Education Group. 27 
 28 
Potential Conflicts of Interest: The authors have no conflicts of interest relevant to this article 29 
to disclose. 30 
 31 
Clinical Trial Registration: ClinicalTrials.gov NCT02907580 32 
Data sharing statement: De-identified individual participant data will not be made available. 33 
 34 
Abbreviations: 35 
aOR – Adjusted odds ratio 36 
IQR – Interquartile range 37 
PACV – The Parent Attitudes about Childhood Vaccines Survey Tool 38 
PACV-5 – The Short-Scale (5 question) Parent Attitudes about Childhood Vaccines Survey Tool 39 
RCT – Randomized controlled trial 40 
 41 
Key words: influenza vaccine, parent education, child vaccine receipt, health communication, 42 
educational intervention 43 
 44 
Table of Contents Summary: This study evaluates brief, clinic-based educational interventions 45 
for parents vs. usual care with child influenza vaccine receipt.  46 
 47 
 2 
What’s Known on this Subject: 48 
Educational interventions have been positively associated with parental intent to vaccinate their 49 
child.  However, analysis of the relationship between clinic-based educational interventions and 50 
pediatric influenza vaccine receipt (rather than parental intent only) is limited. 51 
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What This Study Adds:  54 
A brief educational intervention given to parents in the waiting room prior to a pediatric provider 55 
visit may help improve child influenza vaccine receipt.    56 
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Abstract 71 
 72 
Objective: Assess the impact of a parent educational intervention about influenza disease on 73 
child vaccine receipt. 74 
 75 
Design/Methods: A convenience sample of parents of children ≥6 months-old with a visit at two 76 
New York City pediatric clinics between August 2016-March 2017 were randomized (1:1:1) to 77 
receive either usual care, an educational handout about influenza disease based on local data, or 78 
an educational handout about influenza disease based on national data. Parents received the 79 
handout in the waiting room prior to their visit. Primary outcomes were child influenza vaccine 80 
receipt on day of clinic visit and by end of season. Multivariable logistic regression assessed 81 
associations between intervention and vaccination, adjusting for variables that were significantly 82 
different between arms. 83 
 84 
Results: Parents who received an intervention (vs. usual care) had greater odds of child influenza 85 
vaccine receipt by end of season (74.9% vs 65.4%, aOR 1.68, 95% CI: 1.06-2.67), but not on day 86 
of clinic visit. Parents who received the national data handout (vs. usual care) had greater odds of 87 
child influenza vaccine receipt on day of clinic visit (59.0% vs 52.6%, aOR 1.79, 95% CI 1.04-88 
3.08), but not by end of the season. There was no significant relationship between parents who 89 
received the local data handout (vs. usual care) and child influenza vaccine receipt on day of 90 
clinic visit or by end of season.  91 
 92 
Conclusion: Providing an educational intervention in the waiting room prior to a pediatric 93 
provider visit may help increase child influenza vaccine receipt.  94 
 95 
 96 
Clinical Trial Registration: ClinicalTrials.gov NCT02907580  97 
 5 
Introduction  98 
  99 
Every year in the United States, influenza accrues more than $10 billion in direct medical costs 100 
and has negative health consequences for children, the elderly and those at high-risk of medical 101 
complications.1  Approximately 8 out of 100 children are infected with influenza each year in the 102 
U.S., 20 to 77 out of 100,000 are hospitalized, and an average of 113 children die.2,3  Vaccination 103 
against influenza is the most effective way to prevent the disease.  However, despite the 104 
recommendations by Centers for Disease Control and Prevention (CDC)4 and the American 105 
Academy of Pediatrics5 for all children 6 months or older to receive the yearly influenza vaccine, 106 
U.S. child influenza vaccination rates of 58% nationally remain below the Healthy People 2020 107 
goal of 80%.6,7  108 
 109 
Vaccine hesitancy, which has been linked to vaccine delay or refusal, is on the rise, challenging 110 
public health endeavors to increase influenza prevention.8-11  Parental refusal is often based on 111 
concerns about the safety and effectiveness of vaccines or false beliefs.9,11-13  Healthcare 112 
providers create promotional health information resources to educate and encourage behavior 113 
change in parents and patients.14-17  The content and wording of educational handouts is 114 
important to examine carefully.  For example, pro-vaccine educational handouts attempting to 115 
disprove myths or change parental views may reduce MMR vaccination intention among vaccine 116 
hesitant parents.18  A similar finding has been shown in specific groups of adults and the 117 
influenza vaccine.19  Clinic-based educational interventions have had both significant and 118 
nonsignificant positive associations with vaccine attitudes and behaviors, but not with improving 119 
vaccine uptake.20  Investigating the relationship between brief educational interventions as 120 
adjuncts to the pediatric visit and child influenza vaccine receipt is warranted.   121 
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 122 
The goal of this randomized controlled trial (RCT) was to assess whether providing parents with 123 
an educational handout about influenza disease and the influenza vaccine affects child vaccine 124 
receipt, relative to usual care.  Furthermore, we examined whether using data from a parent’s 125 
local neighborhood versus national data derived from the CDC had an added benefit.  Our 126 
primary hypothesis was that parents who received any educational handout (vs. usual care) 127 
would be more likely to have their child vaccinated against influenza. We additionally 128 
hypothesized that an intervention derived from local data would be more beneficial.  129 
 130 
Methods 131 
 132 
Participants 133 
Between August 2016-March 2017, a convenience sample of parent-child dyads at two pediatric 134 
clinics affiliated with an academic medical center in an underserved area in Northern Manhattan, 135 
New York City, were asked to participate in the study.  Dyads were eligible if the parent spoke 136 
and read either English or Spanish and the child was ≥6 months old, without a contraindication 137 
to the influenza vaccine (including egg allergy), had not already received the influenza vaccine 138 
that season (by parent report), and was not there for an influenza vaccine only visit.  We 139 
calculated that a sample size of 200 parent-child dyads per each of the 3 arms (600 total) would 140 
provide 80% power to detect a 10% difference among arms using chi-square analysis and 141 
a=0.05, and a sample size of 300 per arm would detect a difference of 8%. 142 
 143 
 144 
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Study Design 145 
In this RCT, 1071 parents were approached in the waiting room by a bilingual (English/Spanish) 146 
research assistant prior to their provider visit, as possible without interfering with clinic 147 
registration or clinical care.  All eligible, consented parents completed a baseline survey which 148 
assessed demographics (age, sex, race/ethnicity, parent education, primary language, child’s 149 
insurance, parent type), whether their child was “sick on day of clinic visit,” child’s history of 150 
medical problems and overall health, parental influenza vaccine attitudes and beliefs, knowledge 151 
of influenza disease, and intent to vaccinate both their child and themselves against influenza on 152 
the day of clinic visit and by the end of the season (Appendix A).  Questions were derived from 153 
previously used surveys and based on the Health Belief Model.  Vaccine hesitancy was assessed 154 
at baseline using a 5-question short-scale version21 of the validated 15-question Parent Attitudes 155 
about Childhood Vaccines (PACV) survey tool (Appendix B).22,23    156 
 157 
After the baseline survey, parent-child dyads were randomized into one of three arms (1:1:1 158 
ratio) using sequentially numbered, opaque, sealed envelopes prepared (by author VPS) using 159 
randomly permutated block (generated by author MSS), and stratified by patient’s primary 160 
language (English or Spanish).  Dyads were allocated to their study arm (by research assistant 161 
AB) and received either 1) an educational intervention based on national data, 2) an educational 162 
intervention based on local data, or 3) usual care only.  Both educational interventions consisted 163 
of a single page paper handout which parents read in the waiting room.  The local data 164 
intervention highlighted the risk of influenza, the seriousness of the influenza disease including 165 
referring to a study that showed many people who think they have the flu actually do not, and 166 
vaccine coverage data from the community.24  Information that the “flu shot does not cause the 167 
flu” was also included by referring to a local study in which participants did not have flu-like or 168 
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cold symptoms more often after the influenza vaccine (Appendix C.1).  The national data 169 
intervention highlighted the risk of influenza and vaccine coverage data using national data from 170 
CDC, and information that the “flu shot does not cause the flu” by citing a national study which 171 
showed that people who received a “flu shot vs a saltwater shot did not have more flu-like 172 
symptoms”25-27 (Appendix C.2).  After reading the educational handout, intervention arm parents 173 
were given a post-survey which assessed intent to vaccinate.  They then saw their child’s 174 
pediatric provider for their regular visit.  Parents in the usual care arm answered the baseline 175 
survey only and proceeded to their child’s visit.  Providers were unaware of the parent’s 176 
participation in the study. The child’s medical record was reviewed at the end of the influenza 177 
season in June 2017 and the date of influenza vaccine receipt was documented, which included 178 
synchronization with the New York Citywide Immunization Registry to capture vaccines 179 
received outside of our clinics.  Parents were given a $5.50 New York City subway card for their 180 
participation.  The study was approved by the Institutional Review Board at Columbia 181 
University. 182 
 183 
Measures 184 
The primary outcomes were child influenza vaccine receipt on day of clinic visit and by the end 185 
of the influenza season (i.e. children vaccinated on day of clinic visit plus by end of influenza 186 
season), as abstracted from the medical record.  The primary explanatory variable was any 187 
educational intervention (vs. usual care).  Secondary variables were educational intervention 188 
subgroups (local and national), parental intent to vaccinate, vaccine hesitancy, and attitudes and 189 
beliefs surrounding influenza and the influenza vaccine.  The last documented response was used 190 
for parental intent to vaccinate their child; baseline survey intent for the usual care arm and post- 191 
survey intent for the educational intervention arms.  For vaccine hesitancy, PACV-5 questions 192 
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were answered on a 5 point Likert scale and scored numerically (0,1, or 2), then summed on a 193 
scale from 0 to 10 according to previously used methods.21  Scores were categorized as low (0-194 
4), moderate (5-6), and high (7-10) vaccine hesitancy and dichotomized (≤6 for low/moderate 195 
vaccine hesitancy vs. ≥7 for high vaccine hesitancy) for regression analysis.  Influenza attitude 196 
and belief variables were collapsed from a 4 or 5 point Likert Scale into 2 categories.   197 
 198 
Statistical Analysis  199 
An intention-to-treat analysis was performed as the primary analysis.  A per-protocol analysis 200 
was also conducted which excluded parents who did not complete the study or children who had 201 
already received the influenza vaccine that season (but parent reported they had not been 202 
vaccinated).  Frequency statistics, chi square and Fisher’s exact analyses were used for 203 
describing characteristics of the participants in each study arm, depending on variable type 204 
(categorical vs. continuous). In the primary analysis, multivariable logistic regression was used 205 
to assess the association between any educational intervention and usual care arms with child 206 
influenza vaccine receipt, adjusting for any baseline differences (p ≤ 0.10) among study arms.  In 207 
secondary regression analyses, we assessed the intervention subgroups individually with vaccine 208 
receipt (local data intervention vs. usual care and national data intervention vs. usual care), 209 
adjusting for baseline differences, as well as parental intent to vaccinate, vaccine hesitancy, and 210 
influenza vaccine beliefs/knowledge with child vaccine receipt, adjusting for study arm.  211 
Statistical analyses were conducted with SAS statistical software (version 9.4; SAS Institute Inc. 212 
Cary, NC).  213 
 214 
 215 
 216 
 10 
Results 217 
 218 
Of 1071 parent-child dyads approached, 501 were eligible, 402 were enrolled (80%) and 400 219 
were analyzed (Figure 1).  Median child and parent age was 4.3 (IQR 1.5-9.5) and 33.0 (IQR 220 
27.0-40.0) years, respectively.  As reported by their parent, most children were Latino, publicly 221 
insured, with good to excellent health, and nearly one third of children had a medical problem 222 
and one third were sick on the day of clinic visit.  Parents were mostly Latino mothers, half had a 223 
high school education or less, and one third had previously refused the influenza vaccine for their 224 
child and/or themselves.  Arms were well-balanced with the exception of caregiver education 225 
between the intervention arms and usual care (Table 1).  For the subgroups, differences between 226 
the national data intervention and usual care arms included caregiver education and child sick on 227 
day of clinic visit, and between the local data intervention and usual care arms included child’s 228 
insurance and pre-intervention parental intent to vaccinate child by end of season (Appendix D 229 
Table 1).  Of note, vaccine hesitancy level was not significantly different between the study arms 230 
(Table 1, Appendix D Table 1).  Overall, on the day of clinic visit, 56.8% of child participants 231 
received the influenza vaccine and 71.8% by the end of the influenza season (100% were 232 
inactivated influenza vaccine). 233 
 234 
Parents who received an educational intervention vs. usual care had greater odds of having their 235 
child vaccinated against influenza by the end of the season (74.9% vs. 65.4%, aOR 1.68, 95% 236 
CI: 1.06-2.67), however there was not a significant association with vaccination on the day of 237 
clinic visit (58.8% vs. 52.6%, aOR 1.36 95% CI 0.89-2.09), after adjusting for caregiver 238 
education (Table 2).  Parents who received the national data intervention (vs. usual care) had 239 
greater odds of child influenza vaccine receipt on the day of clinic visit (59.0% vs. 52.6%, aOR 240 
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1.79, 95% CI 1.04-3.08), but not by the end of the season, after adjusting for caregiver education 241 
and child sick on day of clinic visit (Table 2).  There was no significant association for parents in 242 
the local data intervention study arm (vs. usual care) with child influenza vaccine receipt on day 243 
of clinic visit or by the end of the influenza season, after adjusting for child’s insurance and pre-244 
intervention likelihood to vaccinate by end of the season (Table 2).  There was no interaction 245 
between vaccine hesitancy level and study arm in these models.  In per protocol analyses (n = 246 
380), parents who received any intervention (75.1% vs 64.6%, aOR 1.78, 95% CI: 1.11-2.86), 247 
the national data intervention (73.1% vs. 65.4%, aOR 1.76, 95% CI 1.003-3.10) or the local data 248 
intervention (76.7% vs. 65.4%, aOR 1.87, 95% CI 1.07-3.27) had higher odds of vaccinating 249 
their child by the end of the season compared to usual care parents.  250 
 251 
Across all three study arms, parental intent to vaccinate (likely vs. unlikely) was associated with 252 
child influenza vaccine receipt on both the day of clinic visit (69.7% vs. 21.6%, aOR 8.38, 95% 253 
CI 4.85-14.34) and by the end of season (87.4% vs. 29.4%, aOR 18.26, 95% CI 9.94-33.52), 254 
after adjusting for caregiver education and child sick that day. Of the parents who reported “very 255 
likely” to vaccinate (n=251), most did so (89.6%), and of the parents who reported “somewhat 256 
likely” to vaccinate their child (n=110), 74.6% did so by the end of the season.     257 
 258 
Children of parents with low/moderate vs. high vaccine hesitancy had increased odds of 259 
influenza vaccine receipt by the end of the season (74.0% vs. 58.6%, aOR 1.93, 95% CI 1.07-260 
3.48) and on day of clinic visit (58.5% vs. 44.8%, aOR 1.77, 95% CI 1.01-3.10), after adjusting 261 
for study arm.  Parents who reported “no or little concern” (vs. somewhat/very concerned”) with 262 
serious influenza vaccine side effects (68.3% vs. 45.2%, aOR 5.1, 95% CI 3.0-8.5), parents who 263 
reported that the influenza vaccine is “somewhat/very effective” (vs. “somewhat/very 264 
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ineffective”) (67.3% vs. 31.9%, aOR 4.34, 95% CI 2.67-7.05), and parents who did not believe 265 
you can “get the flu from the flu shot” (vs. those who believe you can) (65.3% vs. 52.6%, aOR 266 
1.62, 95% CI 1.03-2.55), had increased odds of having their child vaccinated against influenza 267 
on the day of clinic visit, after adjusting for study arm and child sick on day of clinic visit.  268 
Parent’s belief regarding influenza illness severity was not associated with vaccine receipt.  269 
Findings were similar for child vaccine receipt by the end of the season.  270 
 271 
Discussion 272 
 273 
In this randomized controlled trial, we found that providing an educational handout for parents 274 
was associated with increased child influenza vaccine receipt by the end of the influenza season.  275 
While pro-vaccine educational materials have been previously studied, researchers have 276 
primarily assessed parental vaccine hesitancy and intent to vaccinate,18,19,28,29 a different timeline 277 
or mode of delivery (e.g. text message reminder),29 or focused on adolescent only, adult or 278 
pregnant women populations.30-34  This is one of the first studies to use experimental design to 279 
evaluate the effect of an educational handout intervention in the clinic setting on child influenza 280 
vaccine receipt. Our study adds that a very brief educational intervention for caregivers prior to 281 
seeing a healthcare provider may have lasting effects by helping to increase pediatric vaccine 282 
uptake by the end of the season, and that an educational handout based on national data may 283 
improve influenza vaccination rates on the day of the clinic visit.   284 
 285 
We found that using a targeted approach of the parent’s local community as the data source did 286 
not yield additional benefit to child vaccine receipt.35  The difference in magnitude of the number 287 
of children affected by influenza, and in particular the influenza-related pediatric deaths, 288 
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(national: 85-171 yearly vs. local: 4 yearly) may have made the national data intervention more 289 
impactful in this community.  Also, discussing the higher influenza vaccine coverage rate in the 290 
parent’s local community (80% vs. the lower national rate of 60%) may have not lead to our 291 
hypothesized social desirability impact.  Lastly the local data intervention referred to a study that 292 
showed many people in the community who think they have the flu actually do not.  Instead of 293 
encouraging parents to vaccinate their child because the influenza disease is much more serious 294 
than a cold, perhaps parents were negatively influenced by stating their community members 295 
were wrong.   296 
 297 
Parents with high vaccine hesitancy were less likely to vaccinate their child against influenza 298 
both on the day of clinic visit and by the end of the season.  Previous studies have found similar 299 
associations with vaccine hesitancy and intent, vaccine attitudes, receipt of routine childhood 300 
immunizations, or influenza vaccine declination in the hospital setting.8,23,36-38  Our study extends 301 
this relationship to influenza vaccine receipt in the outpatient setting.  The PACV-5 (short-scale 302 
PACV) used in this study may help to efficiently screen parents in the primary care setting.  The 303 
PACV-5 has been previously analyzed,21 and future research which validates this tool in various 304 
demographics may be useful.  Parental beliefs of influenza vaccine effectiveness, that the flu shot 305 
does not cause the flu, or minimal side effect concerns were also associated with child influenza 306 
vaccine receipt.  Future interventions to promote influenza vaccine effectiveness may be most 307 
useful for impacting child vaccine coverage.  308 
 309 
Self-reported vaccine intent is often used as a surrogate outcome measure instead of receipt in 310 
vaccine research.  Our findings show that parental intent to vaccinate was significantly 311 
associated with child vaccine receipt, although only 89.6% of parents “very likely” to vaccinate 312 
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by the end of the season did so.  For studies where vaccine receipt cannot be captured, our results 313 
support parental intent to vaccinate their child as a very good, but not perfect, proxy for vaccine 314 
receipt.  315 
 316 
The strengths of this study include its randomized controlled trial design and assessment of 317 
baseline vaccine hesitancy and intent to vaccinate to decrease confounding effects. Pediatric 318 
providers were unaware of the parent’s study participation, minimizing social desirability bias.  319 
Assessing influenza vaccine receipt through the child’s medical record improves understanding 320 
of the relationship between self-reported parental intent to vaccinate and whether or not that 321 
aligns with vaccine receipt.  322 
 323 
Study limitations include use of a convenience sample, which may introduce selection bias. 324 
Because the predominant reason for ineligibility was prior child influenza vaccine receipt that 325 
season, those parents who were eligible to enroll, especially later in the season, may have a lower 326 
intent to vaccinate or higher vaccine hesitancy.  Overall child influenza vaccination rate in this 327 
study was 71.8%, slightly less than the 74.1% influenza average vaccine rate for all pediatric 328 
patients seen at those sites.  While this may have resulted in a lower pediatric vaccine receipt 329 
rate, these parents are an important target population in which to assess the impact of pro-vaccine 330 
educational intervention on their decision-making.  Eligible parents who refused to participate 331 
(20%) may have been certain of their decision regarding the influenza vaccine, however we were 332 
unable to view their child’s medical record to measure receipt.  Our study population was 333 
primarily English and Spanish speaking parents in one urban underserved neighborhood, which 334 
may limit generalizability.  There were some differences among study arms, however they were 335 
adjusted for in regression analysis.  We were underpowered due to administrative constraints and 336 
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with more power we may have seen significant differences in other comparisons.  Lastly, we 337 
were unable to control the conversation between the pediatric provider following study 338 
enrollment, which may have varied.  However, use of an experimental design helps to minimize 339 
these unmeasurable differences.  340 
 341 
Conclusion 342 
 343 
In conclusion, a brief educational intervention given in the waiting room prior to a pediatric visit 344 
may help increase child influenza vaccine receipt.  Future research which addresses office-based, 345 
pro-vaccine educational interventions in a various demographics and geographic locations is 346 
warranted.  Comparing modes of information delivery (paper handout, text-messaging, video, 347 
interactive social media) with the goal of including a wider demographic and cost-effectiveness 348 
analyses may help increase child influenza vaccine receipt and promote feasibility of 349 
implementation.   350 
 351 
  352 
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